Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Chen YU, Xu SF, Xu M, Yu XC. Use of negative pressure wound therapy as an adjunct to the treatment of extremity soft-tissue sarcoma with ulceration or impending ulceration. Oncol Lett. 2016 Jul;12(1):757-763. doi: https://doi.org/10.3892/ol.2016.4654. Epub 2016 Jun 1. PMID: 27347212; PMCID: PMC4907320.
2. Siegel GW, Kuzon WM Jr, Hasen JM, Biermann JS. Staged Soft Tissue Reconstruction Following Sarcoma Excision with Anticipated Large Cutaneous Defects: An Oncologically Safe Alternative. Iowa Orthop J. 2016;36:104-8. PMID: 27528845; PMCID: PMC4910795.
3. Kairinos N, Solomons M, Hudson DA. The paradox of negative pressure wound therapy–in vitro studies. J Plast Reconstr Aesthet Surg. 2010;63(1):174–9. https://doi.org/10.1016/j.bjps.2008.08.037 (Epub 2008 Nov 25 PMID: 19036656).
4. Senchenkov A, Petty PM, Knoetgen J 3rd, Moran SL, Johnson CH, Clay RP. Outcomes of skin graft reconstructions with the use of Vacuum Assisted Closure (VAC(R)) dressing for irradiated extremity sarcoma defects. World J Surg Oncol. 2007;29(5):138. https://doi.org/10.1186/1477-7819-5-138.PMID:18047659;PMCID:PMC2219960.
5. Fourman MS, Ramsey DC, Kleiner J, Daud A, Newman ET, Schwab JH, Chen YL, DeLaney TF, Mullen JT, Raskin KA, Lozano-Calderón SA. Temporizing Wound VAC Dressing Until Final Negative Margins are Achieved Reduces Myxofibrosarcoma Local Recurrence. Ann Surg Oncol. 2021 Jun 18. doi: https://doi.org/10.1245/s10434-021-10242-4. Epub ahead of print. PMID: 34143336.